Skip to main content
Signal8

Siu Christine

SEC insider (Form 3/4/5 filer). CIK 0001743029. Director at Monte Rosa Therapeutics, Inc. (GLUE). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BOSTON, MA.

Companies Siu Christine has filed insider reports for

  • Monte Rosa Therapeutics, Inc. (GLUE): Director
Siu Christine profile photo

Siu Christine

CIK: 0001743029

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monte Rosa Therapeutics, Inc. logo
GLUE

Monte Rosa Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Monte Rosa Therapeutics, Inc. logo
    GLUE

    Monte Rosa Therapeutics, Inc.

    Jun 11, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    25.8K shares-
  • Monte Rosa Therapeutics, Inc. logo
    GLUE

    Monte Rosa Therapeutics, Inc.

    Jun 13, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    30.7K shares-

1-2 of 2